APA (7th ed.) Citation

Dreger, P., Rieger, M., Seyfarth, B., Hensel, M., Kneba, M., Ho, A. D., . . . Pott, C. (2007). Rituximab-augmented myeloablation for first-line autologous stem cell transplantation for mantle cell lymphoma: Effects on molecular response and clinical outcome. Haematologica, the hematology journal, 92(1), . https://doi.org/10.3324/haematol.10608

Chicago Style (17th ed.) Citation

Dreger, Peter, Michael Rieger, Bärbel Seyfarth, Manfred Hensel, Michael Kneba, Anthony Dick Ho, Norbert Schmitz, and Christiane Pott. "Rituximab-augmented Myeloablation for First-line Autologous Stem Cell Transplantation for Mantle Cell Lymphoma: Effects on Molecular Response and Clinical Outcome." Haematologica, the Hematology Journal 92, no. 1 (2007). https://doi.org/10.3324/haematol.10608.

MLA (9th ed.) Citation

Dreger, Peter, et al. "Rituximab-augmented Myeloablation for First-line Autologous Stem Cell Transplantation for Mantle Cell Lymphoma: Effects on Molecular Response and Clinical Outcome." Haematologica, the Hematology Journal, vol. 92, no. 1, 2007, https://doi.org/10.3324/haematol.10608.